Sepsis Epidemiology Forecast Report to 2033
November 04, 2024 06:46 ET
|
Research and Markets
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Sepsis: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.Sepsis and septic shock are life-threatening...
Analysis of the Global Sepsis Pipeline, 2024 with Insights on 30+ Companies and 35+ Pipeline Drugs, Including Thymosin Alpha 1 (Sci Clone Pharmaceuticals) and Enibarcimab (AdrenoMed)
May 31, 2024 06:18 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
Global Sepsis Therapeutics Strategic Research Report 2024: Market to Reach $7.1 Billion by 2030 - Market Receives Pulsating Impetus from North America, Asia-Pacific to Witness Fastest Growth
April 19, 2024 06:28 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Sepsis Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Sepsis Therapeutics Market...
Global Sepsis Therapeutics Market Research Report 2023 - Revolutionizing Clinical Sepsis Therapy with Breakthrough Nanoparticles
October 09, 2023 06:18 ET
|
Research and Markets
Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The "Sepsis Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Sepsis Therapeutics Market...
Sepsis Drug Pipeline Research Report 2022: Comprehensive Insights about 40+ Companies and 40+ Pipeline Drugs
December 15, 2022 08:13 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
2021 Sepsis Pipeline Insight with 40+ Companies and 40+ Pipeline Durgs
March 05, 2021 04:13 ET
|
Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Sepsis Pipeline Insight 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights about...
Sepsis Management Analysis, 2020 Report - Treatments Focused Towards Antibiotics, Inhibitors, Antibodies, Peptides, Recombinant Proteins, Antibacterial, Antifungal, Antivirals, Vaccines, & Probiotics
January 12, 2021 09:53 ET
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Analysing Sepsis Management Part II: Treatments" report has been added to ResearchAndMarkets.com's offering. This research study begins by...